|
|
||||||||
European Journal of Cardio-Thoracic Surgery, Vol 11, 943-952, Copyright © 1997 by European Association for Cardio-thoracic Surgery
B Kreitmann, A Riberi, M Zeranska, G Novakovitch and D Metras
OBJECTIVE: An animal model has been used to evaluate the potential of
growth of vascular autografts and allografts, and the effects of
cryopreservation, rejection and immunosuppression on this growth. METHODS:
In 35 animals (seven groups of five female NZW rabbits; age 5- 6 weeks;
weight 1.1 kg), a graft interposition was performed at the level of the
infrarenal aorta. Different groups included fresh autografts, fresh and
cryopreserved consanguineous allografts (donor: litter sister), fresh and
cryopreserved immunosuppressed (IS) consanguineous allografts (receiving
cyclosporin 10 mg/kg per day) and fresh and cryopreserved allografts.
Animals were allowed to grow normally and were sacrificed at the mean
weight of 2.89 kg. We studied the growth of the native aorta and of the
graft and calculated the growth ratio (growth of the graft/growth of native
vessel). Grafts and adjacent aorta were histologically studied. RESULTS:
Growth of the graft was normal (mean ratio 1.08; S.D. = 0.21) for
autografts, and for fresh and cryopreserved IS consanguineous grafts.
Growth was absent (mean ratio 0.12; S.D. = 0.15) for fresh and
cryopreserved allografts (P = 0.0001). In consanguineous grafts without IS,
growth was absent or normal, presumably according to genetic compatibility,
but never intermediate. Histological study showed normal optic microscopic
aspects when growth was normal and, when growth was absent, aspects
compatible with rejection including mainly intimal hyperplasia and medial
thinning. CONCLUSIONS: (1) Normal growth of arterial autografts was
confirmed; (2) cryopreservation did not prevent potential growth of an
arterial graft; and (3) in an allogenic situation, without IS, an aortic
graft, fresh or cryopreserved, never showed any growth potential.
ARTICLES
Growth potential of aortic autografts and allografts: effects of cryopreservation and immunosuppression in an experimental model
Cardiac Surgery, La Timone Children's Hospital, Marseille, France.
This article has been cited by other articles:
![]() |
H. Feier, F. Collart, O. Ghez, A. Riberi, T. Caus, B. Kreitmann, and D. Metras Risk Factors, Dynamics, and Cutoff Values for Homograft Stenosis After the Ross Procedure Ann. Thorac. Surg., May 1, 2005; 79(5): 1669 - 1675. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Jashari, B. Van Hoeck, M. Gaudino, W. Daenen, T. Van Geldorp, P. Kalmar, and Y. Goffin Are pulmonary homografts which were subjected to pulmonary hypertension more appropriate for aortic valve replacement than normal pulmonary homografts? A long-term multicentric echography study Eur. J. Cardiothorac. Surg., February 1, 2000; 17(2): 140 - 145. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |